You must agree not to use any products purchased on this website without taking appropriate measures and precautions against any potential harm that may arise
Where Its ApprovedAnd Why Not in the US Cerebrolysin is approved for treating stroke, traumatic brain injury, and/or dementia in Austria, Germany, Russia, China, South Korea, and approximately 50 other countries across Europe and Asia
It is not an FDA-approved drug, so any clinical use is investigational and provider-supervised
However, most patients notice relief after just one treatment
When glutathione levels are depleted, these immune responses become less efficient